Modafinil in sports: Ethical considerations

British Journal of Sports Medicine

Volumn 39, Issue 4, 2005, Pages 241-244

  Kaufman, K R ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MODAFINIL;

ATHLETE; DOPING; DRUG INDICATION; DRUG MISUSE; ETHICS; HUMAN; NARCOLEPSY; POLICY; REVIEW;

HEALTH CARE AND PUBLIC HEALTH;

BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPING IN SPORTS; FEMALE; HUMANS; NARCOLEPSY; SUBSTANCE ABUSE DETECTION;

EID: 16444387020     PISSN: 03063674     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjsm.2004.016303     Document Type: Review

References (62)

1. International Olympic Committee. Olympic Creed, http://www.janecky.com/ olympic/creed.html (accessed 27 March 2004).
2. International Olympic Committee. Olympic Oath, http://www.janecky.com/ olympic/oath.html (accessed 27 March 2004).
3. International Olympic Committee. Olympic Motto, http://www.janecky.com/ olympic/motto (accessed 27 March 2004).
4. Prendergast HM, Bannen T, Erickson TB, et al. The toxic torch of the modern Olympic Games. Vet Hum Toxicol 2003;45:97-102.
5. Franke WW, Beredonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem 1997;43:1262-79.
6. Cowan DA, Kicman AT. Doping in sport: analytical tests, and legal aspects. Clin Chem 1997;43:1110-13.
7. Eklof AC, Thurelius AM, Garle M, et al. The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology. Eur J Clin Pharmacol 2003;59:571-7.
8. International Olympic Committee. Olympic Movement Anti-Doping Code. Lausanne, Switzerland: International Olympic Committee, 1999.
9. International Olympic Committee. Olympic Movement Anti-Doping Code Appendix A (in force as of 1 January 2003). http://www.cces.ca/WADA-PUB- ProhibitedList2003-E.pdf (accessed 27 March 2004).
10. International Olympic Committee. Olympic Charter (in force as of 4 July 2003). http://multimedia.olympic.org/pdf/en_report_122.pdf (accessed 27 March 2004).
11. Roth T, Roehrs TA. Etiologies and sequelae of excessive daytime sleepiness. Clin Ther 1996;18:562-76.
12. Mitler MM, Harsh J, Hirshkowitz M, et al. Long-term efficacy of modafinil (Provigil) for the treatment of excessive daytime sleepiness associated with narcolepsy. Sleep Med 2000;1:231-43.
13. Schwarte JR, Hirshkowitz M, Erman MK, et al. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open label study. Chest 2003;124:2192-9.
14. Menza MA, Kaufman KR, Castellanos AM. Modafinil augmentation of antidepressant treatment in depression. J Clin Psychiatry 2000;61:378-81.
15. DeBattista C, Lembke A, Solvason HB, et al. A prospective trial of modafinil as an adjunctive treatment of major depression. J Clin Psychopharmacol 2004;24:87-90.
16. Krupp LB. Fatigue in multiple sclerosis: definition, pathophysiology, and treatment. CNS Drugs 2003;17:225-34.
17. MacDonald JR, Hill JD, Tarnopolsky MA. Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy. Neurology 2002;59:1876-80.
18. Webster L, Andrews M, Stoddard G. Modafinil treatment of opioid-induced sedation. Pain Med 2003;4:135-40.
19. Nieves AV, Lang AE. Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil. Clin Neuropharmacol 2002;25:111-14.
20. Hurst DL, Lajara-Nanson W. Use of modafinil in cerebral palsy. J Child Neurology 2002;17:169-72.
21. Rugino TA, Samsock TC. Modafinil in children with attention-deficit hyperactivity disorder. Pediatr Neurol 2003;29:136-42.
22. Kaufman KR, Menza MA, Fitzsimmons A. Modafinil monotherapy in depression. Eur Psychiatry 2002;17:167-9.
23. Turner DC, Robbins TW, Clark L, et al. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) 2003;165:260-9.
24. Xino YL, Fu JM, Dona Z, et al. Neuroprotective mechanism of modafinil on Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Acta Pharmacol Sin 2004;25:301-5.
25. Makris AP, Rush CR, Frederich RC, et al. Wake-promoting agents with different mechanisms of action: comparison of modafinil and amphetamine on food intake and cardiovascular activity. Appetite 2004;42:185-95.
26. Gold LH, Balster RL. Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil. Psychopharmacology (Berl) 1996;126:286-92.
27. Jasinski DR. An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J Psychopharmacol 2000;14:53-60.
28. Camacho A, Stern MB. Modafinil for social phobia and amphetamine dependence. Am J Psychiatry 2002;159:1947-8.
29. Dackis C, O'Brien C. Glutamatergic agents for cocaine dependence. Ann N Y Acad Sci 2003;103:328-45.
30. Engber TM, Koury FJ, Dennis SA, et al. Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil. Neurosci Lett 1998;241:95-8.
31. Lin JS, Hou Y, Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci USA 1996;93:14128-33.
32. Scammell TE, Estabroke IV, McCarthy MT, et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000;20:8620-8.
33. Ferraro L, Tanganelli S, O'Connor WT, et al. The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur J Pharmacol 1996;306:33-9.
34. Ferraro L, Antonelli T, O'Connor WT, et al. The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus. Neuroreport 1997;8:2883-7.
35. Ferraro L, Antonelli T, Tanganelli S, et al. The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. Neuropsychopharmacology 1999;20:346-56.
36. Eriksson KS, Sergeeva OA, Selbach O, et al. Orexin (hypocretin)/dynorphin neurons control GABAergic inputs to tuberomammillary neurons. Eur J Neurosci 2004;19:1278-84.
37. Ramsak B. I can only be Kelli White. http://www.iaaf.org/WCH03/news/ Kind = 2/newsld-22919.html (accessed 27 March 2004).
38. Nichols P. White tests positive for stimulant. http://www.sport/guardian. co.uk/athletics/story/0,10082,10032573,00.html (accessed 27 March 2004).
39. BBC Sport. White under investigation. http://news.bbc.co.uk/sport1/hi/ athletics/world_athletics-2003/3194041.stm (accessed 27 March 2004).
40. Nichols P. White's second positive only serves to muddy waters. http://timesonline.co.uk/printFriendly/0,1-7817-891835,00.html (accessed 27 March 2004).
41. Patrick D. IAAF probing Kelli White drug sample, http://usatoday.com/ sports/olympics/summer/track/2003-08-30-white-doping-probe_x.htm (accessed 27 March 2004).
42. IAAF Communication on the Kelli White Case 3 September 2003. http://www.iaaf.org/news/Kind = 512/newsld = 23089.html (accessed 27 March 2004).
43. IAAF Communication on the Kelli White Case 9 September 2003. http://www.iaaf.org/news/Kind = 512/newsld = 23144.html (accessed 27 March 2004).
44. Schwartz JR, Feldman NT, Fry JM, et al. Efficacy and safety of modafinil for improving daytime wakefulness in patients treated previously with psychostimulants. Sleep Med 2003;4:43-9.
45. Lagarde D, Batejat D, Van Beers P, et al. Interest of modafinil, a new psychostimulant, during a sixty-hour sleep deprivation experiment. Fundam Clin Pharmacol 1995;9:271-9.
46. Li YF, Zhan H, Xin YM, et al. Effects of modafinil on visual and auditory reaction abilities and subjective fatigue level during 48 h sleep deprivation. Space Med Med Eng (Beijing) 2003;16:277-80.
47. Thorpy M. Current concepts in the etiology, diagnosis, and treatment of narcolepsy. Sleep Med 2001;2:5-17.
48. Becker PM, Schwartz JR, Feldman NT, et al. Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy. Psychopharmacology (Berl) 2004;171:133-9.
49. Dauvilliers Y, Billiard M, Montplaisir J. Clinical aspects and pathophysiology of narcolepsy. Clin Neurophysiol 2003;114:2000-17.
50. Johns MW. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test, and the epsworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res 2000;9:5-11.
51. Chabas D, Taheri S, Renier C, et al. The genetics of narcolepsy. Annu Rev Genomics Hum Genet 2003;4:459-83.
52. Silber MH, Krahn LE, Olson EJ. Diagnosing narcolepsy: validity and reliability of new diagnostic criteria. Sleep Med 2002;3:109-13.
53. World Anti-Doping Code (in force as of March 2003). http://www.wada-ama. org/docs/web/statutes_harmonization/code/cod_v3.pdf)(accessed 27 March 2004).
54. IAAF. Control of drug abuse. http://www.tcaa.com.hk/tf/tf_download/iaaf/ 9899/hb9899_3.pdf (accessed 4 April 2004).
55. IAAF. Procedural Guidelines for Doping Control, http://www.sportspro.it/ doping/regolamenti/Reglaaf.pdf (accessed 4 April 2004).
56. O'Brien K. Sympathy but no medal for Romanian gymnast, http://www.abc.net.au/7:30/s192661.htm (accessed 4 April 2004).
57. BBC Sport. US officials admit drug tests. http://news.bbc.co.uk/sportl/ hi/athletics/3358253.stm (accessed 4 April 2004).
58. CBC Sports Online. IAAF official scoffs at "narcolepsy epidemic." http://www.cbc.ca/pcgi-bin/templates/sportsViewcgi?/news/2003/ 10/27/Sports/modafinil_ljungvist031027.htm (accessed 4 April 2004).
59. ABCsportonline. Two-year bans introduced for Modafinil use. http://www.abc.net.au/sport/contents/sl034581.htm (accessed 4 April 2004).
60. Gloster R. USOC confirms Toth's THG, modofinil test. http://www.usatoday. com/sports/olympics/summer/2004-02-16-usoc_x.htm (accessed 4 April 2004).
61. BBC Sport. The THG scandal explained. http://www.news.bbc.co.uk/sport1/ hi/athletics/3210876.stm (accessed 4 April 2004).
62. Gloster R. U.S. seeks tougher anti-drug standards. http://www.detnews. com/2003/moresports/0310/27/sports-305173.htm (accessed 4 April 2004).